Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-08 3:14 pm Purchase |
2025-03-31 | 13G | PMV Pharmaceuticals, Inc. PMVP |
Sio Capital Management, LLC | 3,735,396 7.190% |
163,229 (+4.57%) |
Filing History |
| 2025-02-21 4:02 pm Purchase |
2025-02-13 | 13G | PMV Pharmaceuticals, Inc. PMVP |
PFM Health Sciences, LP | 2,598,827 5.000% |
2,598,827 (New Position) |
Filing History |
| 2025-02-14 10:15 am Purchase |
2024-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP |
BML Investment Partners, L.P. | 3,466,684 6.700% |
196,777 (+6.02%) |
Filing History |
| 2025-02-14 10:06 am Unchanged |
2024-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP |
BML Investment Partners, L.P. | 3,269,907 6.300% |
0 (Unchanged) |
Filing History |
| 2025-02-10 12:58 pm Purchase |
2024-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP |
Sio Capital Management, LLC | 3,572,167 6.900% |
3,572,167 (New Position) |
Filing History |
| 2024-12-12 12:29 pm Purchase |
2024-12-06 | 13G | PMV Pharmaceuticals, Inc. PMVP |
BML Investment Partners, L.P. | 3,269,907 6.300% |
3,269,907 (New Position) |
Filing History |
| 2024-11-14 12:24 pm Purchase |
2024-09-30 | 13G | PMV Pharmaceuticals, Inc. PMVP |
ArrowMark Colorado Holdings LLC | 3,647,291 7.080% |
933,148 (+34.38%) |
Filing History |
| 2024-07-08 4:32 pm Sale |
2024-06-30 | 13G | PMV Pharmaceuticals, Inc. PMVP |
BLACKROCK INC BLK |
1,162,193 2.300% |
-2,067,604 (-64.02%) |
Filing History |
| 2024-04-09 1:17 pm Sale |
2024-03-29 | 13G | PMV Pharmaceuticals, Inc. PMVP |
J P MORGAN CHASE & CO JPM |
15,573 0.000% |
-3,659,241 (-99.58%) |
Filing History |
| 2024-02-14 4:58 pm Sale |
2023-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP |
Citadel Advisors LLC | 1,236,850 2.400% |
-1,022,891 (-45.27%) |
Filing History |
| 2024-02-14 4:02 pm Sale |
2023-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP |
Boxer Capital LLC | 0 0.000% |
-3,163,795 (Position Closed) |
Filing History |
| 2024-02-14 3:38 pm Purchase |
2023-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP |
ArrowMark Colorado Holdings LLC | 2,714,143 5.310% |
2,714,143 (New Position) |
Filing History |
| 2024-02-14 09:18 am Sale |
2023-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP |
AVORO CAPITAL ADVISORS LLC | 0 0.000% |
-3,060,000 (Position Closed) |
Filing History |
| 2024-02-14 07:52 am Sale |
2023-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP |
RTW Investments, LP | 0 0.000% |
-4,356,920 (Position Closed) |
Filing History |
| 2024-02-13 5:12 pm Sale |
2023-12-29 | 13G | PMV Pharmaceuticals, Inc. PMVP |
The Vanguard Group | 2,405,307 4.700% |
-348,299 (-12.65%) |
Filing History |
| 2024-01-29 3:26 pm Sale |
2023-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP |
BLACKROCK INC BLK |
3,229,797 6.300% |
-1,447,231 (-30.94%) |
Filing History |
| 2024-01-23 09:40 am Sale |
2023-12-29 | 13G | PMV Pharmaceuticals, Inc. PMVP |
J P MORGAN CHASE & CO JPM |
3,674,814 7.100% |
-329,953 (-8.24%) |
Filing History |
| 2024-01-23 09:07 am Purchase |
2023-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP |
STATE STREET CORP STT |
723,454 1.410% |
76,904 (+11.89%) |
Filing History |
| 2023-08-23 4:56 pm Sale |
2023-08-09 | 13D | PMV Pharmaceuticals, Inc. PMVP |
ORBIMED ADVISORS LLC | 6,563,077 13.500% |
-26,253 (-0.40%) |
Filing History |
| 2023-07-07 4:35 pm Purchase |
2023-06-30 | 13G | PMV Pharmaceuticals, Inc. PMVP |
BLACKROCK INC BLK |
4,677,028 10.200% |
1,225,661 (+35.51%) |
Filing History |